Tyflox LA: A Broad-Spectrum Antibiotic Solution for Respiratory and Systemic Infections in Livestock

In modern animal husbandry, respiratory and gastrointestinal diseases remain among the most significant challenges affecting animal welfare and farm profitability. These infections not only impact the health of livestock but also reduce productivity, increase mortality, and escalate treatment costs.

Enter Tyflox LA – a powerful long-acting antibacterial solution developed by Sakan Vietnam. With a synergistic combination of Florfenicol and Tylosin, Tyflox LA targets a broad range of bacterial pathogens that cause respiratory and systemic diseases in cattle, pigs, poultry, and companion animals.

What is Tyflox LA?

Tyflox LA is a dual-active veterinary injectable antibiotic designed to treat a wide range of respiratory, gastrointestinal, and systemic infections in livestock. It contains two key active ingredients:

• Florfenicol – 20 g/100 ml

• Tylosin – 5.75 g/100 ml

• Propylene glycol to 100 ml

This formulation allows for deep tissue penetration, prolonged efficacy, and rapid relief from bacterial infections, making it a trusted option for veterinarians and farmers alike.

Key Benefits of Tyflox LA

1. Dual Mechanism of Action

• Florfenicol, a synthetic broad-spectrum antibiotic related to chloramphenicol, works by inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit (Schwarz et al., 2004). It is effective against Gram-negative and Gram-positive organisms, including respiratory pathogens like Pasteurella multocida and Actinobacillus pleuropneumoniae.

• Tylosin is a macrolide antibiotic that also binds to the 50S ribosomal subunit, with strong action against Mycoplasma spp., Staphylococcus, and Streptococcus species (Papich, 2021). It is especially effective in treating enzootic pneumonia and chronic respiratory diseases.

When used together, these two antibiotics provide enhanced antibacterial coverage and a reduced likelihood of resistance development.

2. Broad-Spectrum Indications

Tyflox LA is indicated for the treatment of the following conditions:

• Respiratory Diseases: Pneumonia (acute & chronic), Enzootic pneumonia (caused by Mycoplasma spp.), ORT (Ornithobacterium rhinotracheale), CRD (Chronic Respiratory Disease), APP (Actinobacillus pleuropneumoniae), and PRRS-related secondary infections.

• Gastrointestinal Infections: Salmonellosis, enteritis, diarrhea, and conditions associated with MMA (Mastitis-Metritis-Agalactia) syndrome in sows.

• Systemic Infections: Leptospirosis, Pasteurellosis, and other bacterial diseases responsive to the formulation.

This wide range of applications makes Tyflox LA a go-to solution for mixed infections often seen in intensive livestock farming.

3. Long-Acting and Fast-Acting Formulation

Thanks to its propylene glycol-based carrier, Tyflox LA ensures slow release and sustained therapeutic levels in the bloodstream, allowing for extended efficacy after a single injection. This minimizes stress on animals due to repeated handling and improves compliance with treatment protocols.

4. Reduced Risk of Resistance and Relapse

Combining two different classes of antibiotics lowers the risk of bacterial resistance and increases treatment success. In clinical settings, dual-acting drugs have shown superior performance in preventing relapse and accelerating recovery time (Giguère et al., 2013).

Why Choose Tyflox LA?

• ✅ Broad-spectrum efficacy against respiratory, GI, and systemic infections

• ✅ Dual active ingredients for enhanced bacterial kill rate

• ✅ Extended-release formulation for prolonged action

• ✅ Trusted by veterinarians across diverse livestock systems

• ✅ Produced by Sakan Vietnam, under WHO-GMP standards

Whether you’re managing a cattle operation or a poultry farm, Tyflox LA helps ensure your animals stay healthy, productive, and resilient against bacterial threats.

Conclusion

Tyflox LA is more than just an antibiotic – it’s a comprehensive veterinary solution for modern livestock management. Its synergistic blend of Florfenicol and Tylosin empowers veterinarians and producers to combat some of the most common and costly bacterial diseases affecting animals today.

By choosing Tyflox LA, you’re investing in a product that supports rapid recovery, stronger immunity, and sustainable animal health – all while upholding global standards for responsible antimicrobial use.

References

• Giguère, S., Prescott, J. F., & Dowling, P. M. (2013). Antimicrobial Therapy in Veterinary Medicine. Wiley-Blackwell.

• Papich, M. G. (2021). Saunders Handbook of Veterinary Drugs: Small and Large Animal. 5th ed. Elsevier Health Sciences.

• Schwarz, S., Kehrenberg, C., & Walsh, T. R. (2004). Use of antimicrobial agents in veterinary medicine and food animal production. International Journal of Antimicrobial Agents, 23(2), 161–167.

• Sakan Vietnam. (2024). Tyflox LA Product Sheet. Internal Documentation.